David A. Siegel Vericel Corp Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$32.52 - $52.33 $1.98 Million - $3.19 Million	-60,900 Reduced 92.27%	5,100 $265,000
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $1.8 Million - $2.17 Million	-58,400 Reduced 46.95%	66,000 $2.35 Million
Q3 2023 Nov 14, 2023	SELL	$31.69 - $39.25 $1.8 Million - $2.23 Million	-56,900 Reduced 31.38%	124,400 $4.17 Million
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $200,100 - $264,753	6,900 Added 3.96%	181,300 $6.81 Million
Q1 2023 May 15, 2023	SELL	$23.85 - $31.34 $453,150 - $595,460	-19,000 Reduced 9.82%	174,400 $5.11 Million
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $252,394 - $391,391	14,300 Added 7.98%	193,400 $5.09 Million
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $832,416 - $1.2 Million	36,800 Added 25.86%	179,100 $4.16 Million
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $906,048 - $1.56 Million	39,600 Added 38.56%	142,300 $3.58 Million
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $1.99 Million - $2.71 Million	-62,700 Reduced 37.91%	102,700 $3.93 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $1.12 Million - $1.67 Million	-31,800 Reduced 16.13%	165,400 $6.5 Million
Q3 2021 Nov 15, 2021	BUY	$46.35 - $59.75 $3.94 Million - $5.08 Million	85,000 Added 75.76%	197,200 $9.62 Million
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $1.53 Million - $2.2 Million	-32,500 Reduced 22.46%	112,200 $5.89 Million
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $1.08 Million - $2.08 Million	34,900 Added 31.79%	144,700 $8.04 Million
Q4 2020 Feb 16, 2021	SELL	$18.53 - $31.5 $546,635 - $929,250	-29,500 Reduced 21.18%	109,800 $3.39 Million
Q3 2020 Nov 16, 2020	SELL	$14.68 - $19.12 $597,476 - $778,184	-40,700 Reduced 22.61%	139,300 $2.58 Million
Q2 2020 Aug 14, 2020	BUY	$8.5 - $15.82 $577,150 - $1.07 Million	67,900 Added 60.57%	180,000 $2.49 Million
Q1 2020 May 15, 2020	BUY	$7.25 - $19.22 $132,675 - $351,726	18,300 Added 19.51%	112,100 $1.03 Million
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $539,784 - $752,640	39,200 Added 71.79%	93,800 $1.63 Million
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $598,693 - $795,182	-40,100 Reduced 42.34%	54,600 $827,000
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $1.76 Million - $2.21 Million	-117,100 Reduced 55.29%	94,700 $1.79 Million
Q1 2019 May 15, 2019	SELL	$16.23 - $20.29 $1.33 Million - $1.67 Million	-82,100 Reduced 27.93%	211,800 $3.71 Million
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $60,312 - $103,264	-5,600 Reduced 1.87%	293,900 $5.11 Million
Q3 2018 Nov 14, 2018	BUY	$9.1 - $14.8 $1.4 Million - $2.28 Million	153,900 Added 105.7%	299,500 $4.24 Million
Q2 2018 Aug 14, 2018	BUY	$9.6 - $14.6 $1.26 Million - $1.92 Million	131,700 Added 947.48%	145,600 $1.41 Million
Q1 2018 May 15, 2018	BUY	$5.7 - $12.3 $79,230 - $170,970	13,900 New	13,900 $138,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.5M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account